Zobrazeno 1 - 10
of 179
pro vyhledávání: '"E. Leygue"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robert P. C. Shiu, J R Davie, M Vendetti, Leigh C. Murphy, E Leygue, A Kemp, K Ung, B Peng, A Lewis
Publikováno v:
Journal of molecular endocrinology. 34(2)
To investigate the effect of altered oestrogen receptor (ER)alpha and ERbeta expression on oestrogen and anti-oestrogen action in breast cancer, we have stably expressed an inducible ERbeta1 in MCF7 breast cancer cells. Stably expressing clones were
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L C, Murphy, S L, Simon, A, Parkes, E, Leygue, H, Dotzlaw, L, Snell, S, Troup, A, Adeyinka, P H, Watson
Publikováno v:
Cancer research. 60(22)
The hypothesis that altered expression of specific coactivators/repressors of the estrogen receptor occurs during human breast tumorigenesis in vivo is examined in this study. Using in situ hybridization and reverse transcription-PCR assays, the expr
Autor:
S L, Simon, A, Parkes, E, Leygue, H, Dotzlaw, L, Snell, S, Troup, A, Adeyinka, P H, Watson, L C, Murphy
Publikováno v:
Cancer research. 60(11)
The expression of a specific repressor of estrogen receptor activity (REA) was investigated by a semiquantitative reverse transcription-PCR assay in 40 human breast tumor biopsy samples with respect to steroid hormone receptor status and other known
Publikováno v:
Cancer research. 59(17)
The expression of the recently described steroid receptor RNA activator (SRA) was measured by semiquantitative reverse transcription-PCR within 27 independent breast tumors, spanning a wide spectrum of grade and estrogen receptor (ER) and progesteron
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(8)
The expression of PXR mRNA and a variant PXR mRNA, deleted in 111 nucleotides in the ligand-binding domain, was detected by reverse transcription-PCR amplification in both normal and neoplastic human breast tissues. The level of PXR mRNA did not diff
Publikováno v:
Cancer research. 59(6)
A triple-primer PCR assay was developed, based on the coamplification of estrogen receptor (ER)-beta1, -beta2, and -beta5 cDNAs, to investigate the relative expressions of the corresponding mRNAs in breast cancer lines and in 53 independent breast tu
Publikováno v:
Cancer research. 59(3)
When the level of estrogen receptor (ER)-beta mRNA in tumors, determined by reverse transcription-PCR, was assessed according to either ER status or PR status alone, determined by ligand binding assays, the level of ER-beta mRNA was significantly low
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(10)